Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Value communications

- PMLiVE

Biogen to acquire Apellis in $5.6bn deal

The deal will enhance Biogen’s growth portfolio in immunology and rare disease

- PMLiVE

Matt Ferriday announced as General Manager for LEO Pharma UK

Ferriday most recently held senior leadership roles at Ipsen Biopharma

The Site Factor - printed report

Where it all began: why we wrote ‘The Site Factor’

Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for participants and researchers alike.

Cuttsy + Cuttsy

- PMLiVE

Gilead to acquire Tubulis for up to $5bn

The acquisition builds on Gilead’s oncology pipeline, focused on addressing areas of high unmet need

- PMLiVE

Pistoia Alliance publishes first best-practice framework for ethical social media use in drug development

This marks the Alliance's first direct engagement with oncology, rare disease and cardiology patients

- PMLiVE

Lilly’s Foundayo approved by US FDA as oral GLP-1 for weight loss

Taken at any time of the day, the oral GLP-1 is the only pill to have no food or water restrictions

- PMLiVE

Marking World Health Day on 7 April

From ‘early-signal’ health to lived outcomes: VML Health unveils the new trends set to define health communications

- PMLiVE

PharmaQuest returns: EPA perspectives, through a rare disease lens

By Lottie Sequerra and Emily Morton-West

Amiculum

- PMLiVE

NEW WEBINAR: Maximizing Speed-to-Outcome for Life Science Companies

Stop losing momentum to the "logistics lag." The most successful life science teams have moved beyond fragmented spreadsheets and isolated meetings into a unified orchestration engine. Learn the strategies that...

Impetus Digital

- PMLiVE

Roche opens new Swiss Institute of Human Biology research facility

The new building is part of a 1.5bn euro site investment

- PMLiVE

ReproNovo appoints Mark Altmeyer as Chairman of the Board

Altmeyer previously held senior roles at Arvelle Therapeutics, Axovant, Bristol Myers Squibb and Otsuka

- PMLiVE

Insight gaps leave Biopharma vulnerable to patent cliff crisis, warns expert

With unprecedented patent cliffs looming, putting an estimated $200 to $400 billion in annual global sales at risk , senior strategy consultant and Nmblr founder, Janice MacLennan, is issuing a...

Nmblr

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links